![Per Wold-Olsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Per Wold-Olsen
Ordförande på
ONCOPEPTIDES AB
Förmögenhet: 764 064 $ per 2026-09-30
Profil
Per Wold-Olsen currently works at GN Hearing A, as Chairman from 2008, Oncopeptides AB, as Chairman from 2018, MMV Medicines for Malaria Venture, as Chairman, Senzime AB, as Chairman from 2023, Bio Malter, as Director, and Forepont Capital LLC, as Director.
Mr. Wold-Olsen also formerly worked at MSD (Norge) AS, as Chief Executive Officer & Managing Director from 1976 to 1991, Amarin Corp.
Plc, as Chairman from 2022 to 2023, H.
Lundbeck A, as Chairman-Supervisory Board from 2010 to 2011, Glyconix Corp., as Vice Chairman, GN Store Nord A, as Chairman from 2008 to 2023, GN Audio A, as Chairman, Gilead Sciences, Inc., as Independent Director, Royal Numico NV, as Director, inVentiv Health Clinical, Inc., as Director from 2006 to 2009, World Growth, as Director-Supervisory Board, PharmaSet SAS, as Director, MSD Scandinavia AS, as Regional Director & Vice President, Novo Holdings A, as Director, Merck & Co., Inc., as President-Intercontinental Division from 1974 to 2006, and Exiqon A, as Member-Supervisory Board.
Mr. Wold-Olsen received his Masters Business Admin degree in 1973 from the University of Wisconsin and Masters Business Admin degree from BI Norwegian Business School.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ONCOPEPTIDES AB 0,54 % | 2026-08-27 | 2 065 678 ( 0,54 % ) | 452 528 $ | 2026-09-30 |
SENZIME AB 0,72 % | 2025-09-23 | 1 126 344 ( 0,72 % ) | 311 535 $ | 2026-09-30 |
Senaste nyheterna om Per Wold-Olsen
| 2025-09-23 | Senzimes ordförande köper aktier för 0,3 miljoner | FW |
| 2025-04-24 | Senzimes styrelseordförande köper aktier för 0,6 miljoner kronor | FW |
Aktiva positioner av Per Wold-Olsen
| Företag | Position | Start |
|---|---|---|
| ONCOPEPTIDES AB | Ordförande | 2018-05-17 |
| SENZIME AB | Ordförande | 2023-11-01 |
Bio Malter | Direktör/Styrelseledamot | - |
Forepont Capital LLC
 Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Direktör/Styrelseledamot | - |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Ordförande | 2008-06-16 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Ordförande | - |
Tidigare kända positioner av Per Wold-Olsen
| Företag | Position | Slut |
|---|---|---|
| GN STORE NORD A/S | Ordförande | 2023-03-15 |
| AMARIN CORPORATION PLC | Ordförande | 2023-02-28 |
| H. LUNDBECK A/S | Ordförande | 2011-03-30 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Per Wold-Olsens utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
80
Första gradens relationer
23
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 23 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Royal Numico NV
 Royal Numico NV Food: Specialty/CandyConsumer Non-Durables Manufactures baby food and clinical nutrition products | Consumer Non-Durables |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Glyconix Corp.
 Glyconix Corp. Pharmaceuticals: MajorHealth Technology Manufactures anti infective and oncology drugs | Health Technology |
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
GN Store Nord A/S
 GN Store Nord A/S Telecommunications EquipmentElectronic Technology Provides telecommunications and hearing instruments | Electronic Technology |
GN Audio A/S
 GN Audio A/S Electronic Production EquipmentElectronic Technology Develops, manufactures, and markets corded and wireless headsets, amplifiers for headsets, and headset telephones | Electronic Technology |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
BI Norwegian Business School
 BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
World Growth | |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
PharmaSet SAS
 PharmaSet SAS Medical SpecialtiesHealth Technology Manufactures and distributes disposable healthcare kits for hospital use | Health Technology |
MSD (Norge) AS
 MSD (Norge) AS Pharmaceuticals: MajorHealth Technology Engages in researching, manufacturing and marketing of drugs | Health Technology |
Bio Malter | |
MSD Scandinavia AS | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Forepont Capital LLC
Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Finance |
